Fig. 3

Allele-specific copy number analyses of the next-generation sequencing data revealed loss of chromosome 9 and gain of chromosome 17 in all nine cases. Mutational analysis did not reveal FH mutation in any of the tumors. This figure shows loss of chromosome 9 and gain of chromosome 17 in all five cases analyzed by Memorial Sloan Kettering Cancer Center compared with the normal diploid chromosomes